Clinical safety and efficacy of combination of sustained-release morphine and transdermal fentanyl patch to the dyspnea in lung cancer patients
Not Applicable
- Conditions
- lung cancer
- Registration Number
- JPRN-UMIN000001958
- Lead Sponsor
- Kobe University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with severe cardiac dysfunction 2. Patients with severe renal or liver dysfunction 3. Patients with increased intracranial pressure 4. Patients with skin disorders such as atopic 5. Patients have a fever of more than 40 degree centigrade 6. Patients with impaired consciousness 7. Other than the orally drug (suppository drug and injection) is administered to patients by drug route of morphine
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Improvement of dyspnea
- Secondary Outcome Measures
Name Time Method